Altre lingue Fulgent Genetics, Inc.

Azioni

FLGT

US3596641098

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/04/2024			Variaz. 5gg	Var. 1 gen.
20,03 ^USD	-3,42%		-0,40%	-30,72%

07/03	FULGENT GENETICS, INC. : Piper Sandler ribadisce il giudizio Neutral	ZM
29/02	FULGENT GENETICS, INC. : rating Neutral da UBS	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024	11/04
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	28/02
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	28/02
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results	28/02
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M	28/02
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28	28/02
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024	13/02
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels	09/02
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing	09/02
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing	09/02
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference	14/11
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting	03/11
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting	03/11
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	03/11
Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
Fulgent Reports Third Quarter 2023 Financial Results	03/11
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2023	03/11
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting	25/10/23
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023	17/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Fulgent Genetics, Inc.

Azioni

FLGT

US3596641098

Altre lingue

Filtri